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The Collagen Binding 11 Integrin VLA-1
Regulates CD8 T Cell-Mediated Immune Protection
against Heterologous Influenza Infection
tissues, including the lung, no organ-specific receptors
have been described and may not be necessary. In com-
parison to memory T cells isolated from central lymphoid
sites, the T cells isolated from a variety of nonlymphoid
tissues exhibit altered functional capacities, such as
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In the mouse, experimental infection of C57BL/6 mice
A common feature of many infections is that many with serologically distinct influenza H3N2 A/HK/x31
pathogen-specific memory T cells become estab- (X31) and H1N1 A/PR8 (PR8) viruses is a well-character-
lished in diverse nonlymphoid tissues. A mechanism ized model of heterosubtypic immunity (Bennink et al.,
that promotes the retention and survival of the memory 1978; Effros et al., 1977, 1978; Liang et al., 1994; Yewdell
T cells in diverse tissues has not been described. Our et al., 1985). In most strains of mice, X31 produces a
studies show that the collagen binding 11 integrin, fairly benign infection, with peak cellular infiltration of
VLA-1, is expressed by the majority of influenza-spe- the lung at day 8, clearance of the virus by day 9, and
cific CD8 T cells recovered from nonlymphoid tissues rarely produces death even when a high inoculum dose
during both the acute and memory phases of the re- (105 EID50) is administered (Allan et al., 1990). PR8 infec-sponse. Antibody treatment or genetic deficiency of tion, on the other hand, causes death in the majority of
VLA-1 decreased virus-specific CTL in the lung and infected B6 mice, even when low doses of virus (102
other nonlymphoid tissues, and increased them in the EID50) are used (Ennis et al., 1976). The internal nucleo-spleen. In spite of the increase in the spleen, second- protein (NP) is shared between the two viruses (Tite et
ary heterosubtypic immunity against flu was compro- al., 1990), and prior immunization with X31 elicits NP
mised. This suggests that VLA-1 is responsible for reactive CD8 cytotoxic T lymphocytes (CTL), specific for
retaining protective memory CD8 T cells in the lung an H2-Db-restricted epitope of the internal nucleoprotein
and other tissues via attachment to the extracellular (NP366–374), that can protect mice from PR8 challengematrix. (Bennink et al., 1978; Effros et al., 1977, 1978). Yet this
heterosubtypic protective immunity can wane with time
(Liang et al., 1994), a phenomenon related to the numberIntroduction
of flu-specific CD8 T cells in the lung (Hogan et al.,
2001a).It is becoming increasingly clear that effector/memory
This latter issue is relevant to understanding the per-T cells in peripheral nonlymphoid tissues are important
sistence of T cell memory and protection. CD8 memoryduring secondary encounters with pathogens. Following
T cells against viral antigens persist indefinitely in sec-primary exposure to infection, both CD4 and CD8 patho-
ondary lymphoid organs (Doherty et al., 1996, 1997;gen-specific T cells distribute to virtually all lymphoid
Wherry et al., 2003). However, a number of reports haveand extralymphoid sites (Hogan et al., 2001a; Marshall
demonstrated that, in spite of substantial numbers ofet al., 2001; Masopust et al., 2001; Reinhardt et al., 2001).
memory CD8 T cells in the spleen and lymph nodes,For some tissues, such as skin and gut, the tissue-
protection against infection in nonlymphoid organs isspecific homing receptors have been defined (Butcher
short-lived (Bachmann et al., 1997; Hogan et al., 2001a;and Picker, 1996; Kunkel and Butcher, 2002). For other
Liang et al., 1994). In the flu system, CD8 T cell-mediated
protective heterosubtypic immunity in the upper and*Correspondence: david_topham@urmc.rochester.edu
lower respiratory tract of BALB/c mice is short-lived,5 Present address: Alnylam Pharmaceuticals, 790 Memorial Drive,
Cambridge, Massachusetts 02139. disappearing 4 to 6 months after priming (Liang et al.,
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1994). Though there were many flu-specific CD8 T cells
in the spleen, this protection was later shown to depend
on the number of virus-specific CD8 T cells resident in
the lung (Hogan et al., 2001a). A similar phenomenon
discovered using the LCMV model suggested the loss
of peripheral immune protection was related to the acti-
vation status of the memory CD8 T cells (Bachmann et
al., 1997). In this model, despite long lasting elevated
precursor frequencies to LCMV in the “central” lymphoid
tissue, immune protection against infection in “periph-
eral” (nonlymphoid) organs was short-lived (Bachmann
et al., 1997). It was suggested that there is a time-depen-
dent loss of effector CTL and that persisting antigen is
essential to keep CTL poised to act against emerging
infections (Bachmann et al., 1997). Taken together,
these studies suggest that efficient secondary immune
protection depends on the presence of activated ef-
fector/memory T cells in the peripheral tissues.
One of the major T cell surface receptors for collagen
is the 11 integrin heterodimer, originally designated
as Very Late Antigen (VLA)-1 (Hemler et al., 1986). VLA-1
primarily binds to type IV, but also type I, collagen (Belkin
et al., 1990; Hemler, 1990). Analysis of the expression of
1 (CD49a) integrin expression on cells from secondary
lymphoid organs reveals little detectable expression on
resting peripheral T cells (Bank et al., 1991; Goldman et
al., 1992; Hemler, 1990; Stemme et al., 1992). While the
role of VLA-1 on T cells in disease is not known, infiltrat-
ing T cells have been observed in vivo to express VLA-1
in the synovium of rheumatoid arthritis (Hemler et al.,
1986; Takahashi et al., 1992) and in atherosclerotic
plaques (Stemme et al., 1992). Treatment of mice with
hamster mAbs that block VLA-1 (Ha 31/8) (Mendrick et
al., 1995) abrogate the induction of both experimental
rheumatoid arthritis and delayed type hypersensitivity
(DTH) responses (de Fougerolles et al., 2000). No evi- Figure 1. Expression of VLA-1 on CD4 and CD8 Cells before and
after Infection with Influenza A/HK/x31dence for functional deletion of effector cells was appar-
Spleen (SPL), MLN, and BAL cells were harvested from B6 femaleent, since treated mice responded normally when the
mice prior to infection (A) or 8 days after intranasal infection withblocking antibody treatment was suspended (de Fou-
influenza A/HK/x31 (B–D).gerolles et al., 2000). Similarly, 1-deficient mice were
(A and B) VLA-1 expression was analyzed on CD4 and CD8 cells
resistant to the induction of arthritis and hypersensitivity subsequent to staining with anti-CD4-APC, anti-CD8-TC, and anti-
reactions (de Fougerolles et al., 2000), supporting that VLA1-Alexa488 and gating on either CD4or CD8 live lymphocytes.
(C) VLA-1 expression on flu NP- and PA-specific CD8 T cells wasthe mode of action for the mAb inhibition studies is
determined after staining BAL cells with anti-VLA1-Alexa488, DbNP-related to diminished VLA-1 function. Both the DTH and
PE or DbPA-PE tetramers, and anti-CD8-TC, and gating on thearthritis models are examples of inflammation driven by
CD8 cells.
CD4 T cells (Hernandez-Pando and Rook, 1994; Seki et (D) Secretion of IFN- in response to either NP or PA peptides (10
al., 1989), making a strong case for the role of VLA-1 in M) determined by intracellular cytokine staining with anti-VLA1-
Alexa488, anti-IFN- PE, and anti-CD8-TC, and then gating on CD8inflammatory CD4 T cell biology. In the human lung,
cells. Numbers in the quadrants indicate the percent of positiveVLA-1-positive T cells have been found compartmental-
cells in that quadrant or region, with the number in parenthesesized on the epithelial surface of the lower respiratory
indicating the percent of VLA-1 cells within the tetramer or
tract (Saltini et al., 1988), and these lung T cells appeared IFN- subsets.
to exchange very slowly with the systemic lymphoid
organs (Saltini et al., 1988).
We propose that VLA-1 mediates the retention of pro- Results
tective effector/memory CD8 T cells in the lung and
other nonlymphoid organs. This explains how virus-spe- VLA-1 Is Expressed by the Majority of Peripheral CD8
cific CD8 T cells generated during a localized infection T Cells during Influenza Virus Infection
can be found within diverse tissues unrelated to the Examination of VLA-1 expression in lymphoid organs of
initial infection. It suggests that this phenomenon is a naive 8-week-old C57BL/6 mice reveals minor popula-
general feature of T cells in providing secondary immu- tions of CD4 and CD8 T cells that express VLA-1 (Figure
1A, day 0). Interestingly, even in these resting animals,nity in a variety of organs.
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though few lymphocytes can be isolated from the lung Virus-Specific VLA-1-Expressing CD8 T Cells
Accumulate in the Lung during Resolutionby bronchoalveolar lavage (BAL), a substantial propor-
tion of the CD4 (26%) and CD8 (31%) T cells express of the Infection
Infection with influenza virus results in permanent in-VLA-1 (Figure 1A), much greater than that seen in the
draining mediastinal lymph node (MLN, 2%–3%) or the creases in lymphocyte numbers in the lung (Doherty et
al., 1997). During the initial phase (days 0–8) of a primaryspleen (8%).
Strikingly, respiratory infection with influenza X31 immune response to flu, the number of CD8 T cells in
the lung increases by three orders of magnitude. Repli-causes a substantial increase in the numbers of both
CD4 and CD8 T cells that express VLA-1 (Figure 1B). cation of the virus is controlled within 9 days of inocula-
tion in B6 mice, and the inflammatory response resolvesThe cellular immune response to influenza peaks 8 days
after inoculation (Allan et al., 1990), and at this time the (Topham and Doherty, 1998). During this resolution
phase, the number of CD8 T cells in the lung drops bymajority (63%) of CD8 T cells in the lung express VLA-1.
CD4 T cells in the BAL also express VLA-1 (40%). Again, one to two orders of magnitude (Tripp et al., 1995a) but
does not return to preinfection levels. Many of the CD8the proportion of CD4 or CD8 T cells expressing VLA-1
in the MLN and spleen is modest at 3%–5% in the MLN T cells infiltrating the lung during the acute phase un-
dergo deletion by apoptosis as the infection resolvesand 9%–16% in the spleen. These observations show
that this Very Late Antigen (Hemler et al., 1985) is ex- (Belz et al., 1998), presumably due to diminishing viral
antigens. However, a few flu-specific CD8 T cells remainpressed early during virus infection in an organ-selective
manner, suggesting that some important signal is pres- in the lung for extended periods of time (Hogan et al.,
2001a). Analysis of VLA-1 expression on the Db/NPent in this context that was missing from the in vitro
cultures where VLA-1 was originally described (Hemler CD8 T cells 14 days after infection (Figure 2A) revealed
that the cells remaining in the lung were predominantlyand Jacobson, 1987).
VLA-1, while those in the MLN were mostly VLA-1,
and those in the spleen and blood (not shown) were
mixed. This was the first indication that VLA-1 mightExpression of VLA-1 on Flu-Specific CD8 T Cells
during the Infection affect the distribution of virus-specific CD8 T cells, with
the VLA-1 population favoring nonlymphoid tissues.There is very little nonspecific recruitment of CD8 T cells
to the lung during influenza infection (Topham et al., To determine how this affected the flu-specific CD8
T cell population, CD8 T cells were costained with2001). Since VLA-1 was expressed by most of the CD8
T cells in the lung, it was likely that many of these were either DbNP or DbPA tetramers and Ha31/8 antibody to
1. Analysis of 1 expression on the tetramer cellsinfluenza specific. To investigate this possibility, CD8
T cells from the BAL, lung tissue, MLN, and spleen were in the lung showed that these CD8 T cells selectively
increased in proportion as the infection resolved (Figurestained with H2-Db class I MHC tetramers containing
the immunodominant nucleoprotein (NP366–374) and acid 2B). The increase in the proportion of flu-specific VLA-1
CD8 T cells after clearance of virus was not maintainedpolymerase (PA224–233) peptide epitopes (Belz et al., 2000;
Flynn et al., 1998). At the peak of the acute primary in the MLN or spleen. The data are particularly striking
considering that this is the period of time when the totalimmune response (d8), 71% and 77%, respectively, of
the NP or PA tetramer CD8 T cells in the BAL also number of lymphocytes in the lung is exponentially
dropping.expressed VLA-1 (Figure 1C). These proportions are
similar to those seen for the CD8 population as a whole.
The data make it clear that, even among CD8 T cells Reduced Apoptosis among the VLA-1
with identifiable virus specificity, there are two subpopu- CD8 T Cells in the Lung
lations defined by VLA-1 integrin expression. We sought to explain how the VLA-1 subset of CD8
The differences between the VLA-1 and VLA-1 CD8 T cells might accumulate in the lung. As the number of
populations in the lung were not known. Certainly, the CD8 T cells in the lung drops during resolution of flu
presence of CD8 T cells in the lung lacking VLA-1 expres- infection, most of these cells die by apoptosis (Belz et
sion suggested that this integrin was not essential for al., 1998). Though many of the apoptotic cells are rapidly
CD8 T cell recruitment. Alternatively, expression might cleared from lung and some accumulate in the liver (Belz
be acquired in the lung environment. On the other hand, et al., 1998), a substantial number of cells probably die
expression of VLA-1 on some flu-specific CD8 T cells in the lung and are cleared by alveolar macrophages.
in the MLN and spleen suggests that some CD8 cells To determine whether the VLA-1-expressing population
can express VLA-1 outside of the infected lung. might have some survival advantage, we used theTUNEL
To determine whether VLA-1 integrin expression cor- assay (Darzynkiewicz et al., 1992) to estimate the pro-
related with effector function, BAL CD8 T cells were portion of CD8 T cells undergoing apoptosis.
stimulated with NP366–374 or PA224–233 in the presence of At 8 days after infection, the cellular immune response
brefeldin A and then analyzed for intracellular IFN- (Belz is at its peak, and virus is being cleared rapidly. This
et al., 2000; Flynn et al., 1998). Of the CD8 T cells that rapid loss of antigen may drive the passive apoptosis
produced IFN-, roughly 80% were also positive for of the virus-specific CD8 T cells (Van Parijs and Abbas,
VLA-1 (Figure 1D). Thus, it appears that for the CD8 1998). At this time point, the VLA-1 population of CD8
T cells that can be defined as effectors by IFN- secre- T cells showed reduced apoptosis compared to the
tion, though VLA-1 expression correlates with effector VLA-1 subset (Figure 2C). This is in direct contrast to a
report that 21 integrin (VLA-2)-expressing CD8 T cellsfunction, it does not identify 100% of the effectors.
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Figure 2. Persistence of Flu-Specific VLA-1
CD8 T Cells in the Lung
(A) Fourteen days after infection of B6 mice
with influenza A/X31, the BAL, MLN, and
spleen were harvested and CD8 T cells ana-
lyzed with Db/NP-PE tetramer and anti-1-
Alexa488 Ha31/8 mAb. Values in the quad-
rants indicate the percent of positive cells.
The percentage of VLA-1 cells among the
tetramer cells is indicated by the numbers
in parentheses.
(B) The relative prevalence of VLA-1 CD8
DbNP cells over the course of the infection
was determined by flow cytometric analysis
of BAL, MLN, and SPL cells subsequent to
staining with anti-1-Alexa488, DbNP-PE tet-
ramer, and anti-CD8-TC.
(C) The BAL of day 8 X31-infected mice was
analyzed for apoptosis by TUNEL staining of
CD8 VLA-1 and CD8 VLA-1 cells. Data
are representative of four experiments.
(D and E) Fifty-three days after infection with
X31, CD8 BAL cells were analyzed by flow
cytometry for VLA-1 and VLA-2 expression
(D) and VLA-1 versus DbNP or DbPA tetramers
among the CD8 cells (E).
were more likely to apoptose in the context of influenza cessed for immunohistochemistry. Formalin- or zinc-
fixed serial tissue sections from day 30 flu-immune miceinfection (Kambayashi et al., 2001). Our data suggest
that the VLA-1 CD8 T cells in the lung have a unique were stained with the trichrome stain to identify collagen
(Figures 3A and 3D), H&E (Figure 3B), or anti-CD8 (Fig-survival advantage, perhaps related to signals delivered
through VLA-1. ures 3C and 3D). CD3 and CD8 cells could be seen
in the interstitium adjacent to conducting airways andReduced apoptosis among the VLA-1 CD8 T cells
may partially explain how this population becomes pre- vasculature, where trichrome staining (blue) was evi-
dent, suggesting a close association with collagen. Dualdominant as the infection is resolved. Increased survival
and the adhesive functions of VLA-1, which would be anti-CD8 and trichrome staining was performed to help
assess the relationship between the CD8 cells andpredicted to localize T cells to areas of collagen, might
combine to create a model in which VLA-1 is instrumen- the collagen deposits. CD8 cells were clearly localized
within the interstitial areas surrounding the airways andtal in the establishment of memory T cells in non-
lymphoid tissues. major blood vessels (Figure 3D), where collagen content
is greatest as seen in the trichrome stain. This staining
pattern fits with the expected distribution of type I andPersistence of VLA-1 CD8 T Cells in Recovered Animals
and Proximity to Collagen IV collagen (the primary substrates for VLA-1), which
constitute important structural components of the peri-Approximately 2 months after infection with influenza,
analysis of CD8 T cells recoverable by BAL revealed a vascular and peribronchial interstitium (type I) as well
as the basement membranes (type IV) of vascular endo-significant population of CD8 T cells in the lung that
expressed VLA-1 (Figure 2D). Further analysis of the thelium and airway epithelium (Miner and Sanes, 1994;
Sado et al., 1998).CD8 T cells in the lung by staining with DbNP or DbPA
tetramers showed that 79%–84% of DbNP and DbPA
tetramer-positive CD8 T cells were VLA-1 (Figure 2E). Activation Profiles of VLA-1 CD8 T Cells
Previous studies describing the presence of virus-spe-Together, the data suggest that, as the infection re-
solves, there is a selective retention of VLA-1 CD8 cific CD8 T cells in nonlymphoid tissues showed that
these T cells had an activated profile usually associatedT cells in the lung. The high proportion of CD8 T cells
in the lung that express VLA-1, and the more limited with effector/memory cells (Masopust et al., 2001). To
investigate whether the VLA-1 population of CD8distribution of VLA-1 on T cells in the secondary
lymphoid organs, suggested to us that perhaps it was T cells matched this effector/memory T cell profile, 30
days after X31 infection, we analyzed the VLA-1 CD8functioning to localize the CD8 CTL within areas of ac-
cessible collagen in the lung tissue. To investigate this T cells for the activation markers CD69, CD25, CD44,
1B11, and CD62L. The majority of the VLA-1 CD8possibility, lungs of influenza immune mice were pro-
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Figure 3. Localization of T Cells in the Lungs
of Recovered Mice to Areas of Collagen Adja-
cent to Conducting Airways and Activation
Markers on the VLA-1 CD8 T Cells
Thirty days after X31 infection, lungs were
obtained from recovered animals for immu-
nohistochemical analysis of collagen deposi-
tion and localization of CD8 cells. Lungs
were inflated with a 1:1 PBS/OCT mixture.
(A–D) Histology and immunohistochemical
staining. Serial sections of zinc-fixed lungs
were prepared and stained with (A) trichrome
to mark collagen deposits (blue); (B) hema-
toxylin and eosin; (C) rat anti-CD8, devel-
oped with biotinylated rabbit anti-rat second-
ary, streptavidin-horse radish peroxidase,
and DAB (black) to identify T cells (hematoxy-
lin counterstain); and (D) dual CD8 immuno-
histochemical and trichrome collagen stain-
ing to demonstrate colocalization of CD8
T cells and collagen in the peribronchial and
perivascular connective tissue.
(E) Peripheral lymphocytes were isolated and
stained for CD8 and VLA-1, and after gating
on the CD8 VLA-1 lymphocytes, the ex-
pression of CD44, CD62L, 1B11 (CD43), and
CD69 was analyzed after additional staining
with activation marker-specific mAb as de-
scribed in the Experimental Procedures. AV,
alveolus; AW, airway; BV, blood vessel.
T cells in the lung were CD69, CD25, CD44high, 1B11, the antiviral T cells and is in line with published reports
utilizing the same antibodies (de Fougerolles et al.,and CD62Llow (Figure 3E), including the DbNP and DbPA
tetramer-positive subsets (not shown). This phenotype 2000). The data also show that inhibition of VLA-1 did
not inhibit primary recruitment of T cells to the lung.suggests that perhaps these T cells are poised for
mounting rapid effector functions should the pathogen To further test whether VLA-1 integrin was involved
in the recruitment of activated CD8 T cells to the infectedbe reencountered. Thus they could be important in sec-
ondary immunity. lung, the following adoptive transfer study was per-
formed. Lung lymphocytes from day 8 X31 flu-infected
Thy-1.2 B6 mice were collected by bronchoalveolarVLA-1 Is Not Essential for Recruitment of CD8 T Cells
to the Lung during Primary Infection lavage and stained with either an isotype control ham-
ster Ig (Ha 4/8) or the anti-VLA-1 hamster antibodyTo investigate whether VLA-1 integrin participated in the
process of T cell recruitment to the lung, animals were (Ha31/8). Flow cytometric analysis of these cells prior
to transfer revealed that 56% were CD8, and 75% oftreated with a monoclonal antibody against the 1 sub-
unit (Ha31/8) of VLA-1, which blocks binding to collagen the CD8 cells also expressed VLA-1. The cells were then
adoptively transferred by i.v. injection into day 6 X31-(Mendrick et al., 1995), or a control hamster Ig (Ha4/8).
Each animal received 250 g of each affinity-purified, infected Thy1.1 B6.PL congenic hosts. The hosts were
also treated with 250 g of the same anti-1 or controlendotoxin-free antibody every other day beginning prior
to inoculation with virus and continuing on alternate hamster mAb. Twenty-four hours later, the BAL was
collected and analyzed for the presence of Thy1.2 do-days throughout the course of the experiment. No repro-
ducible effect was seen on the numbers of CD8 T cells nor CD8 T cells (Figure 4B). The number and proportion
of Thy1.2 CD8 T cells in the BAL was identical in bothor DbNP tetramer-positive CD8 T cells in the lung (Figure
4A). DbNP CD8 T cells in the MLN were also unaffected the control and anti-1-treated groups. We concluded
that VLA-1 does not participate in the recruitment of(not shown), but they were significantly (p  0.01) in-
creased in the spleen at day 10 (Figure 4A), suggesting CD8 T cells to the infected lung and that the anti-1 H
31/8 monoclonal antibody does not deplete the acti-redistribution had occurred. Viral clearance was similar
in both groups (data not shown). The high expression vated CD8 T cells.
Finally, in mice genetically deficient in 1 integrinof VLA-1 on the virus-specific CD8 T cells during the
infection, the absence of an effect of anti-1 on viral (VLA-1 KO), primary infection with X31 revealed no in-
crease in susceptibility to infection, or defect in the con-clearance, and minimal changes in cell distributions
strongly suggest that the Ha31/8 mAb does not deplete trol of viral replication (data not shown). The proportions
Immunity
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VLA-1 does not have a major role in the recruitment of
immune cells to the lung during infection.
Presence of VLA-1 CD8 T Cells in Other Tissues
and the Diaspora Effect
An emerging paradigm in viral immunity is that the
pathogen-specific T cells can distribute through all the
tissues of the body, even those that were not inflamed
or involved in the primary infection (Masopust et al.,
2001; Reinhardt et al., 2001). For example, after an influ-
enza infection, the flu-specific CD8 T cells undergo a
“diaspora” effect that distributes them to many if not all
organs (Doherty et al., 2000; Marshall et al., 2001). It is
not known whether these cells come from the lung or
secondary lymphoid organs. To see whether the appear-
ance of flu-specific VLA-1 CD8 T cells was organ spe-
cific, affecting only the lung, several other nonlymphoid
tissues were sampled. We found that in most organs
the majority (74%–88%) of CD8 T cells isolated from
nonlymphoid tissues expressed VLA-1, while in the
lymphoid organs VLA-1 CD8 T cells were a minority
(Table 1). When the flu-specific CD8 T cells were identi-
fied with tetramers, the pattern persisted with 79%–94%
of the flu-specific CD8 T cells in the nonlymphoid organs
expressing VLA-1 (Figure 2E and Table 1). As has been
described (Hogan et al., 2001a), flu-specific CD8 T cells
persist in the lung for several months, and we find that
these continue to express 1 integrin even 6 months
after the primary infection (not shown).
The data support two conclusions. First, VLA-1 ex-
pression identifies a population of CD8 T cells that may
be selective for nonlymphoid tissues, and, second, since
not all the CD8 T cells in the tissue were VLA-1, there
are at least two subpopulations of CD8 T cells that mi-
Figure 4. VLA-1 Is Not Essential for Recruitment of CD8 T Cells to
grate to nonlymphoid tissues. Alternatively, the CD8the Infected Lung
T cells may acquire VLA-1 expression within the tissues(A) B6 mice were treated with Ha 31/8 mAb to block VLA-1 (open
by an undefined mechanism.bars) or a control (Ha 4/8, solid bars), receiving 250 g of each
antibody beginning 3 days prior to infection and continuing on alter-
nate days throughout the course of the experiment. Individual spleen Blocking VLA-1 in Immune Mice Reduces
and pooled BAL cells were harvested and counted from five mice the Number of Memory CD8 T Cells
at 7 and 10 days after infection and analyzed for the presence of in the Periphery
CD8 DbNP tetramer cells by flow cytometry. Data are representa-
The preferential accumulation of VLA-1 NP-specifictive of three experiments, and the error bars indicate one standard
CD8 T cells led us to hypothesize that VLA-1 integrin-deviation from the mean of the five mice within one experiment.
mediated binding might be responsible for the retention*p  0.01.
(B) 7	 105 BAL lymphocytes (75% VLA-1) from day 8 X31-infected of T cells in the lung and other nonlymphoid tissues.
Thy1.2 B6 mice were treated with anti-1 (Ha31/8) or control (Ha Since VLA-1 binds to types I and IV collagen compo-
4/8) mAb and transferred i.v. into day 6 X31-infected Thy1.1 con- nents of extracellular matrix (Hemler, 1990), it could re-
genic recipients. BAL of the recipient mice was sampled 24 hr later
tain T cells within tissue via attachment to collagen.for the presence of the donor Thy1.2T cells. Values in the quadrants
To test this hypothesis, influenza-immune animals (50indicate the percent of positive cells in that quadrant.
days after primary infection) were treated with anti-1(C) Influenza A/X31 immune B6 mice (3 months after X31 infection)
were treated with either Ha31/8 anti-VLA-1 or control Ha 4/8 mAb (Ha 31/8), or control hamster Ig (Ha 4/8) mAb prior to
(250 g i.p.) on days 5, 3, and 1 prior to sampling. Animals were harvesting lymphocyte populations. The lymphocytes
then analyzed by flow cytometry for the presence of flu-specific were then stained for CD4 and CD8, as well as DbNP
CD8 T cells in the liver (average of four individual mice 
 SD) and
and DbPA influenza tetramers. This treatment reducedBAL (pooled from four mice) after CD8 and Db/NP or Db/PA tetra-
the proportion of CD8 T cells that were flu NP- or PA-mer staining.
specific by 40%–50% in the BAL and by 90% in the liver
(Figure 4C). The difference between the BAL and liver
results may reflect the ability of the antibody to reachof virus-specific CD8 cells in the lung were also similar
to wild-type mice (not shown). This indicates that there the VLA-1 cells or that CD8 T cells in the airways have
a more limited ability to return to the circulation. In naiveare no defects in the ability to generate a protective
primary influenza-specific T cell response in the ab- (uninfected) -1-deficient mice, analysis of CD44high/
CD62Llow/CD8 T cells in the spleen, salivary gland, andsence of VLA-1. These results strongly support those
obtained using blocking antibodies and establish that liver also revealed reductions in the salivary gland (10%
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Table 1. Predominance of VLA-1 CD8 T Cells among Nonlymphoid Organs Compared to Lymphoid Organs
Of the CD8
Of the CD8 Cellsc DbNP Cellsd
Organa CD8 (%)b DbNP (%) VLA-1 (%) VLA-1 (%)
BAL 20.9 12.2 76.4 86.9
lung 44.6 11.1 80.7 94.2
Nonlymphoid kidney 3.8 33.1 74.4 94.3
liver 7.5 2.5 86.5 88.0
salivary gland 10.6 34.3 88.0 88.0
CLN 23.0 0.4 0.4 31.8
MLN 22.6 1.4 2.1 16.1
Lymphoid MesLN 25.8 0.7 0.9 56.7
spleen 11.9 3.1 6.0 68.2
PBL 24.6 0.7 4.0 16.9
a C57BL/6 female mice were infected with influenza A X31 and allowed to recover from infection. Fifty to sixty days after infection, lymphocytes
were isolated from the indicated organs by excision, treatment with collagenase and DNAse, and disruption in a Dounce homogenizer.
b Single-cell suspensions were stained with anti-CD8-TC (CT-CD8a), and the percent CD8 cells within a lymphocyte gate determined by flow
cytometric analysis.
c Single-cell suspensions were stained with anti-CD8-TC (CT-CD8a), anti-VLA1-Alexa488 (Ha31/8), and DbNP-PE tetramer. Cells were analyzed
by flow cytometry after gating on lymphocytes and CD8 events to determine the percent of CD8 cells that were tetramer or VLA1.
d After gating on lymphocytes that were positive for both CD8 and DbNP tetramer, the proportion of these that were VLA-1 was determined.
versus 39%) and liver (8% versus 26%), and a slight Similar VLA-1 blocking studies were performed at 1–2
months and also at more than 6 months after primaryincrease of these cells in the spleen (4% versus 3%).
On the basis of these observations, we suggest that in X31 infection. At 1–2 months there was no difference in
survival between the anti-1 and control mAb groupsthe periphery there are two populations of recirculating
memory T cells, one defined by expression of VLA-1 (not shown), likely reflecting the high number of circulat-
that is resident or passing relatively slowly out of the
tissue and another more rapidly recirculating pool that
favors secondary lymphoid organs.
Compromised Secondary Immunity
via Inhibition of VLA-1
The number of memory CD8 T cells present in the lung
determines the effectiveness of secondary immune pro-
tection (Hogan et al., 2001a). The number is highest
immediately following infection and has been shown to
wane with time (Hogan et al., 2001a). When the number
drops below a certain threshold, protection in the lung
from secondary infection is reduced (Hogan et al.,
2001a, 2001b; Liang et al., 1994; Wiley et al., 2001). We
hypothesized that if the number of flu-specific memory
CD8 T cells in the lung is reduced by blocking VLA-1,
then immune control of a secondary infection should
be compromised.
The H3N2 HKx31 and H1N1 PR8 strains of influenza A
are serologically distinct (Bennink et al., 1978). However,
both viruses share the internal nucleoprotein, seen by
immune CD8 CTL. Furthermore, these crossreactive
Figure 5. VLA-1 Blockade Reduces the Number of Flu-Specific CD8CTL can protect immune mice from lethal challenge with
T Cells in the Periphery and Compromises Secondary Heterosub-PR8 (Bennink et al., 1978). Three months after primary
typic Immune Protection
infection, influenza A/HK/x31 immune mice were pre-
Influenza A/HK/x31 (H3N2) immune B6 mice (3 months after primarytreated with 1 blocking mAb as above (250 g on alter-
X31 infection) were treated with either Ha31/8 anti-1 or control Ha
nating days 5, 3, and 1), prior to challenge with a normally 4/8 mAb (250 g i.p.) on days 5, 3, and 1 prior to intranasal challenge
lethal dose (3 	 105 EID50) of influenza A/PR8. At 6 days with 3 	 105 EID50 lethal influenza A/PR8 (H1N1).
(A) Animals were analyzed 6 days after PR8 challenge by flow cytom-after PR8 inoculation, the anti-1 mAb-treated mice ex-
etry for the presence of DbNP-specific CD8 T cells in the lung byhibited a reduced proportion of the DbNP tetramer CD8
BAL (pooled) after CD8 and Db/NP tetramer staining.T cells in the lung (Figure 5A). More importantly, 70%
(B) Animals were monitored for survival after PR8 challenge (2of the anti-1 mAb-treated mice succumbed to the PR8
experiments 	 5 mice per group  10 total). Nonimmune animals
infection by day 9, compared to only 20% of the control (n  5) were also monitored for morbidity after PR8 challenge. The
hamster Ig-treated mice, and all of the nonimmune ani- mean survival time between the control and anti-VLA-1-treated
groups was significantly different (p  0.01, unpaired t test).mals (Figure 5B).
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ing flu-specific T cells at this early period. Conversely,
after 6 months, both the control group and the anti-1-
treated mice had become highly susceptible, presum-
ably because the number of virus-specific CD8 T cells
in the lung needed for protection had naturally waned
by this time (Hogan et al., 2001a). These experiments
demonstrate that the resident flu-specific CD8 T cells in
the lung that provide heterosubtype-specific protection
are dependent on VLA-1.
Reduction of Tissue Resident Memory CD8 T Cells
and Enhanced Susceptibility to Secondary
Influenza Infection in VLA-1-Deficient Mice
Primary infection of 1-deficient mice with influenza
A/X31 gave no evidence that these animals were com-
promised in the ability to control, at least, this primary
infection. However, the blocking antibody experiments
suggested that inhibition of VLA-1 can compromise sec-
ondary heterosubtypic influenza immunity. As dis-
cussed above, this system is unique in that secondary
immune protection is entirely dependent on the number
of NP-specific CD8 T cells in the lung at the time of
Figure 6. 1 Integrin Deficiency Alters the Distribution of NP-Spe-
challenge (Hogan et al., 2001a, 2001b; Liang et al., 1994; cific CD8 T Cells and Enhances Susceptibility to Secondary Virus In-
Wiley et al., 2001). If our hypothesis is correct, then the fection
absence of VLA-1 on the T cells should decrease the Wild-type and 1 integrin-deficient B6 mice were primed with influ-
number of flu-specific memory T cells in the lung and enza A/HK/x31 (H3N2) as described.
(A) Three months after priming, the animals were sampled for theenhance susceptibility to PR8 challenge.
presence of flu-specific Db/NP tetramer CD8 T cells in the BAL,To test these predictions, 1 integrin-deficient and
lung tissue, MLN, and spleen. Three animals per group were ana-wild-type B6 mice were primed with X31 as usual. After
lyzed, with the BAL and lung tissue lymphocytes remaining afterrecovery, the animals were allowed to rest for 3 months.
lavage pooled, while the MLN and spleen samples were analyzed
They were then analyzed for the presence of influenza independently. Error bars indicate the standard deviation of the
NP-specific CD8 memory populations in the MLN, mean for the three animals.
(B) The remaining mice were challenged with influenza A/PR8 (H1N1)spleen, BAL, and lung tissue by DbNP tetramer staining.
at 3	 104 or 3	 105 EID50 per mouse in two independent experimentsIn line with the results obtained with blocking antibodies,
(five per group in each experiment) and monitored for survival. Mor-mice deficient in 1 integrin had significant decreases
tality in each group was similar in both experiments, so the datain the number of flu-specific CD8 T cells, particularly in
were combined into a single figure. Comparison of the mean survival
the BAL, but also in the lung tissue remaining after la- time between the two groups gave a p 0.10 by the unpaired t test.
vage (Figure 6A). Conversely, there were significant in-
creases in flu-specific memory CD8 T cells in the MLN
and spleen indicating no general defect in the ability increases in the lymph node and spleen may explain
why the VLA-1-deficient animals were not quite as sus-to generate CD8 memory T cells when 1 integrin is
deficient. However, the data do suggest that, in the ceptible compared to the antibody-treated animals.
Namely, that these “central memory” T cells (Sallustoabsence of VLA-1, the T cells are unable to be retained
in the long term in the lung. et al., 1999; Wherry et al., 2003) can provide effective,
though perhaps not optimal, protection in some circum-Based on the reduction in the number of flu-specific
CD8 T cells in the lung, it follows that the animals should stances. Together, these observations suggest that, in
the lung, CD8-mediated immune protection from hetero-display increased susceptibility to secondary PR8 chal-
lenge. In two separate experiments, wild-type and 1 subtypic influenza is dependent on localized virus-spe-
cific memory T cells that require VLA-1 to be retainedintegrin-deficient B6 mice were primed with H3N2 influ-
enza A/X31 as described above. The animals were in this extralymphoid compartment. The data further
suggest that in this system, which depends on virus-rested for 3 months and then inoculated with H1N1 influ-
enza A/PR8 at 3	 104 or 3	 105 EID50 per mouse. In each specific CD8 T cells, the memory CD8 T cells in the
spleen and MLN are not adequate to provide optimalexperiment, 40% of the 1-deficient mice succumbed to
the infection within 8 days of inoculation. One wild-type protection.
animal succumbed at the 3 	 105 EID50 dose of virus.
The cumulative data from these experiments are pre- Discussion
sented in Figure 6B. Thus, as was the case with the
blocking antibodies, the reduction in the number of flu- An essential element of cellular immune memory and
protection is the capacity to establish and retain patho-specific CD8 T cells in the lung that occurs when VLA-1
is inhibited, resulted in enhanced susceptibility to sec- gen-specific cells. Following clonal expansion during a
primary immune response, populations of memory CD8ondary challenge. This enhanced susceptibility oc-
curred in spite of an increased number of flu-specific T cells become established both in the secondary
lymphoid organs and in a variety of peripheral non-CD8 T cells in the secondary lymphoid organs. These
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lymphoid tissues. The importance of memory T cells in integrins on activated versus naive or perhaps periph-
eral versus central memory (Sad and Mosmann, 1994;extralymphoid sites was not known, but it was specu-
lated that they could be important for secondary immu- Sallusto et al., 1999; Wang and Mosmann, 2001; Wherry
et al., 2003) T cells can be understood in terms of theirnity (Masopust et al., 2001). However, a mechanism to
explain how these cells become initially established and activation requirements and roles in immunity.
The role of VLA-1 integrin has been investigated inare then retained was missing.
Our studies of the collagen binding integrin VLA-1 several in vivo models of inflammation using an anti-
VLA-1 (anti-1 integrin) Ha 31/8 mAb that blocks thebegan with the hypothesis that binding to the abundant
matrix material within solid organs was an essential adhesion of activated T cells to collagen type I and IV
(Andreasen et al., 2003; de Fougerolles et al., 2000; Ia-physical component of how pathogen-specific CTL
would migrate toward infected target cells. This hypoth- naro et al., 2000; Mendrick et al., 1995). Treatment of
animals with this antibody inhibits the effector phaseesis may still be valid, however, the studies also revealed
two additional elements of collagen binding integrin inflammatory responses in models of delayed-type hy-
persensitivity, contact hypersensitivity (CHS), and arthri-function in T cell biology, namely survival and retention.
The interstitial environment and basement mem- tis (de Fougerolles et al., 2000). No evidence for func-
tional deletion of effector cells was apparent, sincebranes through which lymphocytes must migrate is rich
in extracellular matrix (ECM). The most abundant types treated mice responded normally when the blocking an-
tibody treatment was suspended (de Fougerolles et al.,are the collagens, which in the lung account for 15% of
its dry weight (Blankenship et al., 1993; van Kuppevelt 2000). In a rat arthritis model, anti-1 mAb was found
to block secondary lesion formation, and T cells in theet al., 1995). T cells encounter ECM in the secondary
lymphoid organs in a way that is fundamentally different draining lymph nodes had reduced expression of IL2
receptor and proliferative responses (Ianaro et al., 2000).from the way they encounter ECM in peripheral tissues.
Peripheral tissues are bounded by epithelium on a base- Similarly, 1-deficient mice were resistant to the induc-
tion of arthritis and hypersensitivity reactions (de Fou-ment membrane composed of mostly type IV collagen
and laminin (Dustin and de Fougerolles, 2001; Miner and gerolles et al., 2000), supporting that the mode of action
for the mAb is related to the inhibition of VLA-1 function.Sanes, 1994), while the intercellular space in the tissues
is largely composed of mostly type I collagen fibrils Several different cell types can participate in these in-
flammatory responses, including both CD4 and CD8(Dustin and de Fougerolles, 2001). Thus, T cells entering
and migrating through peripheral tissues are constantly T cells. Neither the cell types affected in these studies
nor the effect of the anti-1 mAb on a particular cellin contact with collagen. Histological examination of a
variety of extralymphoid tissues shows that most lym- type was documented.
In another model of viral infection, LCMV induced de-phocytes localize near epithelial or endothelial bound-
aries, at or near basement membrane, rich in the ligand layed type hypersensitivity, the majority of LCMV-spe-
cific CD8 T cells were found to express1 integrin duringfor VLA-1, type IV collagen.
The organization of ECM and the accessibility to lym- the acute (57%) and memory (80%) phases of the
immune response (Andreasen et al., 2003). Similar tophocytes in lymph nodes, on the other hand, is vastly
different. Collagen fibrils in the lymph nodes are sheathed the observations here with influenza-specific CD8
T cells, the LCMV-specific memory CD8 T cells in theby fibroblastic reticular cells of the reticular fiber net-
work (Gretz et al., 2000). These reticular conduits for spleen were found to have a bimodal distribution of
VLA-1 on their surface (Andreasen et al., 2003), againsoluble factors and antigens (Gretz et al., 1996, 2000) are
located in the interfollicular areas, distal to the germinal suggesting that two independent populations of mem-
ory CD8 T cells can be distinguished by VLA-1. In con-centers (Young, 1999). Because the collagen in the node
is largely hidden from the T cells, they are much less trast to our findings, inhibition of 1 by antibody or
deletion delayed the primary DTH response in the foot-likely to engage ECM.
It has been hypothesized (Dustin and de Fougerolles, pad, though the maximal response was similar to the
controls (Andreasen et al., 2003). This response was2001) that these differences in the accessibility of colla-
gen between lymphoid and nonlymphoid tissues are restored by transfer of the LCMV-primed spleen cells
directly into the footpad (Andreasen et al., 2003), consis-related to the way T cells are activated in the two sites.
T cells in solution can form clusters with dendritic cells tent with the ideas that a certain number of antigen-
specific cells are needed at the inflammatory site for anand thereby increase the duration of MHC TCR synapse
formation to encourage T cell activation (Dustin and de optimal response and that VLA-1 may be important for
regulating this in the periphery.Fougerolles, 2001). This is essentially the situation in the
lymph nodes and favors the activation of naive T cells. In During influenza infection, as with many virus infec-
tions, there is a massive clonal expansion in the numberthe presence of collagen, T cells are stimulated to mi-
grate (Gunzer et al., 2000; Shields et al., 1984). In colla- of virus-specific CD8 T cells. The number of CTL gener-
ated is far in excess of what is necessary to fight offgen gels and presumably in tissues, T cells form only
transient interactions with DC and other cells (Gunzer the infection (Tripp et al., 1995b), and most of the cellular
progeny die as the infection is resolved. Most of theet al., 2000). This would favor the effector or memory
T cells that can be rapidly activated, while discouraging death is believed to be by passive apoptosis subsequent
to reduced antigen load and IL2 secretion (Van Parijsthe activation of naive or resting T cells that require
prolonged interaction with MHC and costimulation to and Abbas, 1998), since mice deficient in either Fas or
FasL seem to eliminate excess T cells normally at thebecome activated (Dustin and de Fougerolles, 2001).
Thus, the organization of ECM in lymphoid versus non- end of a response (Lohman et al., 1996; Razvi et al.,
1995). In spite of a high rate of apoptosis, some virus-lymphoid tissues and the expression of collagen binding
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specific CD8 T cells survive and continue to be retained during acute and memory phases of an immune re-
sponse, and that in vivo this resistance is conveyedin the lung and other peripheral sites for extended peri-
ods of time. Similar to our own observations, it was through VLA-1. The resistance of the VLA-1 subpopula-
tion of virus-primed T cells in the lung would promote therecently reported that lymphocytic choriomeningitis vi-
rus-specific CD8 T cells in peripheral tissues are more establishment and maintenance of a resident memory
population for protection against future secondary en-resistant to apoptosis than those in lymphoid organs
(Wang et al., 2003). The question is what distinguishes counters with related pathogens.
The second essential element of establishing andthose cells destined to survive from those that will die.
To survive, they must have a potent mechanism to inhibit maintaining extralymphoid memory T cells would be the
capacity to physically retain the cells in the tissue forthe apoptotic pathways inside the cell.
Anchorage-dependent cells such as epithelial and en- some period of time. It is well accepted that activated
and memory T cells have the capacity to enter inflameddothelial cells are exquisitely dependent on integrin-
mediated attachment to collagen to prevent apoptosis. tissues from the circulation (Mackay et al., 1992). This
recruitment is largely antigen specific, though a minorityThe death that accompanies detachment of epithelial
cells from collagen substrate is termed “anoikis” (Frisch of nonspecific memory T cells may be recruited in a
bystander fashion, at least early in a response (Tophamand Francis, 1994) and has been implicated in pre-
venting damaged or mutated cells from migrating to et al., 2001). What is less clear is whether memory T cells
can enter into noninflamed tissues, though it seemsother tissues. While T cells are clearly not all anchorage
dependent, this does not mean that matrix attachment plausible that this activity would be a feature of normal
immune surveillance. An alternative hypothesis is thatdoes not promote resistance to apoptosis, though such
a mechanism would be predicted to be distinct at a acutely activated T cells might enter many, if not all,
tissues during an acute immune response, and thatmolecular level from that which drives anoikis.
We have observed that in the lung VLA-1-expressing some of these cells are retained as memory cells after
entry. This hypothesis is supported by the observationsCD8 T cells are resistant to the apoptosis that follows
recovery from influenza infection. The molecular mecha- that T cells are intimately associated with collagen in
the lungs of flu-immune mice and flu-specific cells enternism that conveys this resistance is not currently known,
and is under investigation. In a related system, DX5 tissues other than the lung.
We cannot yet resolve whether the memory T cells ininfluenza-specific CD8 T cells were observed to have
an increased susceptibility to apoptosis (Kambayashi the lung were established during, or after, the virus was
cleared. Our data demonstrate that inhibition of VLA-1et al., 2001). Though the identity of the DX5 ligand was
unknown at the time, the DX5 mAb has more recently does not inhibit recruitment of influenza-specific CD8
T cells to the lung during infection, suggesting that re-been shown to recognize the 2 integrin chain (Arase
et al., 2001). The large proportion of the flu-specific CD8 cruitment is not dependent on VLA-1 expression. Once
the infection is resolved, a population of predominantlyT cells also express 2 integrin during the infection, but
most of these cells are either lost or downregulate 2 VLA-1 virus-specific CD8 T cells is recoverable from
the lung and other tissues. This phenotype is not uniqueafter the virus is cleared (data not shown). A differential
susceptibility to apoptosis related to the expression of to the flu-specific cells, since analysis of CD8 T cells in
naive mice reveals a similar, but smaller, populationeither 1 or 2 integrin would suggest an important role
for 1 in the establishment of CD8 memory T cells. The of predominantly VLA-1 cells that resemble the flu-
specific cells. This suggests that other immune chal-predominance of VLA-1CD8 T cells in the lung and their
close proximity to endothelium and epithelium, versus lenges or pathogens may evoke populations of VLA-1
tissue memory cells. Perhaps most importantly, inhibi-parenchymal locations, suggests that memory CD8
T cells are preferentially and selectively directed to these tion of VLA-1 by blocking antibody or genetic deletion
compromises this extralymphoid population of memorylocations by the pattern of adhesion molecules they ex-
press. CD8 T cells in the lung. Though our studies indicate
that VLA-1 expression is a stable feature of flu-specificContrary to the observation that 2 flu-specific
T cells are at increased risk of apoptosis, Aoudjit and memory CD8 T cells in the lung, the number of recover-
able cells has been shown to naturally wane with timeVuori (2000) described that 21-mediated attachment
to type I collagen increases resistance of Jurkat T cells (Hogan et al., 2001a), demonstrating that these memory
cells do not persist indefinitely. This suggests that theseto Fas-mediated death. This appeared to be mediated
via 21-triggered downmodulation of FasL expression. memory T cells are not static but may either exchange
in a limited fashion with lymphocytes in circulation orAlthough this contrasts the situation reported during
influenza infection for DX5 (i.e., 21) CD8 T cells eventually die. In either case, adhesion to collagen may
increase the half-life of these cells in the tissue, thereby(Kambayashi et al., 2001), it may be explained by the
different forms of cell death that are occurring. Fas- optimizing local secondary immunity for some time after
the initial challenge. Acceleration of this loss of tissueand FasL-deficient mice appear to delete excess T cells
normally during resolution of viral infections (Lohman et memory by inhibition of VLA-1 increases susceptibility
to secondary challenge with a virus that the unmanipu-al., 1996; Razvi et al., 1995), suggesting that the deletion
occurs by passive means. 2 would not be protective lated animals can easily resist.
In conclusion, these studies have revealed an impor-in this situation, though perhaps 1 offers some pro-
tection. tant role for integrin-mediated matrix attachment in
T cell immunity. A mechanism has been described toOn the basis of our current observations, we propose
that integrin-mediated ligation of type I or type IV colla- explain how pathogen-specific CD8 T cells can be es-
tablished and retained in nonlymphoid tissues. Thisgen may convey resistance to apoptosis of CD8 T cells
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and the gall bladder removed. Livers were dispersed into single-mechanism has important implications for the design of
cell suspension by passing through wire mesh and then washed invaccine strategies to enhance immune protection. It may
40 ml. Each was then digested in 10 ml HBSS containing 2 mgalso be an important target for immune therapies aimed
collagenase IV (Sigma C-5138) and 0.2 mg DNase I (Sigma DN-25)
at reducing T cell-mediated inflammation, such as might for 35 min at 37C with constant rocking. The digested slurry was
occur during allergic reaction. We may also have to diluted to 40 ml and subjected to three 30G spins for 3 min each
to remove debris. The supernatant was then pelleted and resus-revise our view of secondary immunity. The disruption
pended in 26% metrizamide (Sigma M-3383) in HBSS. This wasof immune protection that results when the number of
overlaid with 2 ml HBSS and centrifuged at 4C for 20 min, 1500 g,virus-specific CD8 T cells in the lung is reduced demon-
with no brake. Interface was retrieved, washed in 10 ml, and pelletedstrates that one of the first lines of defense in secondary
at 600 g for 5 min. All cell counts were obtained by trypan blue ex-
immunity is the memory T cells in the peripheral tissues. clusion.
This idea is reminiscent of that proposed by Bachmann
et al. (1997), in which it was demonstrated that second- Flow Cytometric Analysis
ary immunity in peripheral organs can become compro- Lymphocyte populations were stained as aliquots of 2 	 105 cells
mised despite substantial numbers of memory T cells with various combinations of mAbs to CD8 (53-6.72 or CT-CD8a),
Thy1.1 (OX-7), Thy1.2 (30-H12), CD44 (IM7), and anti-CD62L (MEL-in the central lymphoid organs. It is possible that the
14) conjugated to FITC, phycoerythrin (PE), biotin, APC, or PE-Cy5.gradual loss of peripheral immunity is linked to the loss
The conjugated mAbs were purchased from Pharmingen (San Diego,of VLA-1 function or expression on tissue-resident mem-
CA) or Caltag (Burlingame, CA) and are referenced in their current
ory T cells. catalogs. Tetrameric complexes of H-2Db/influenza PA224–233 (DbPA)
and H-2Db/influenza NP366–374 (DbNP) were prepared by the Trudeau
Experimental Procedures Institute Molecular Biology Core Facility and used as described
previously (Belz et al., 2000; Flynn et al., 1998). All cells were ana-
Animals lyzed with CellQuest software (Becton-Dickinson, San Diego, CA),
Female C57BL/6 (B6) mice were purchased from Taconic Farms using either a Becton-Dickinson FACScan in three-color mode or a
(Germantown, NY) at 6 weeks of age. Congenic Thy1.1 B6.PL mice Becton-Dickinson FACSCalibur in four-color mode.
were purchased from Jackson Laboratory (Bar Harbor, ME). 1 in-
tegrin-deficient (VLA-1-deficient, VLA-1 KO) (Gardner et al., 1996)
Intracellular Cytokine Analysismice backcrossed on to the B6 background were provided by Bio-
Spleen, MLN and nonadherent BAL populations were cultured forgen, Inc. and a colony maintained at the University of Rochester.
6 hr in 96-well round-bottom plates at 5 	 105 to 8 	 105 cells perAll animals were housed in the University of Rochester Vivarium
well in complete medium containing 10 g/ml brefeldin A (Epicenterfacilities under SPF conditions using microisolator technology. Pri-
Technologies, Madison, WI), with or without 10 M of the influenzamary inoculation with influenza virus was performed in animals 8–12
NP366–372 or PA224–233 peptides. After culture, the cells were placed onweeks of age.
ice, washed in PBS/brefeldin A (10 g/ml), stained with a cocktail
of anti-1-Alexa 488 and anti-CD8-tricolor, washed again, fixedViruses
with 1% formaldehyde, permeablized in 0.5% saponin (Sigma, StThe H3N2 A/Hong Kong/X31 (X31), and H1N1 A/Puerto Rico/8 (PR8)
Louis, MO), and stained with anti-IFN--PE (Pharmingen) for 30 mininfluenza viruses were grown and titered in embryonated chicken
on ice. The lymphocytes were then washed and analyzed in three-eggs and harvested as allantoic fluid preparations (Allan et al., 1990).
color mode with CellQuest software.
Primary and Secondary Influenza Infection
TUNEL Assay of ApoptosisFor primary infections, mice were sedated with avertin (2,2,2-tribro-
Lymphocytes were harvested from infected animals at the timesmoethanol) prior to intranasal (i.n.) challenge with 105 EID50 of X31 in
indicated, stained for surface marker expression, and then washed30 l of PBS. For secondary heterosubtypic challenge, X31 immune
in PBS. Stained cells were fixed in 4% paraformaldehyde for 15 minmice were sedated with avertin and intranasally inoculated with 103
at room temperature, washed, and then resuspended in 0.1% TritonEID50 of PR8.
X100 in 0.1% sodium citrate to permeabilize the cells. After washing
in PBS, the cells were then stained by the TUNEL method usingIntegrin-Specific Antibodies
the TMR Red In Situ Cell Death Detection Kit (Roche MolecularThe function blocking hamster mAb Ha31/8 against 1 (Mendrick
Biologicals, Mannheim, Germany). Positive controls consisted ofet al., 1995) and the anti-KLH Ha 4/8 control mAb were affinity
thymocytes cultured overnight in 105 M dexamethasone.purified in an azide-free, low-endotoxin format at Biogen, Inc. For
the in vivo blocking studies, each animal received 250g of antibody
every other day beginning 3 days prior to inoculation with virus and Histology and Immunohistochemistry
continuing on alternate days throughout the course of the experi- Lungs were inflated with 1:1 mixture of PBS and OCT infused
ment. For flow cytometry, the antibodies were conjugated to through the trachea and fixed in 0.5% ZnCl2 (tris-calcium acetate
Alexa488 or biotin according to the directions of the manufacturer buffer [pH 7.3]) for 24 hr. Sections (5 M) were cut from paraffin-
(Molecular Probes, Eugene, OR). embedded blocks and stained with either hematoxylin and eosin
(H&E) for routine histologic examination, trichrome to delineate col-
lagen (Gomori, 1950), or immunohistochemistry (IHC). Slides wereCell Isolations
Following cardiac perfusion of the mice with PBS, the trachea was deparaffinized, treated with 3% H202 in H20 for 6 min to quench
endogenous peroxidase activity, and pretreated for 20 min withcanulated and bronchoalveolar lavage cells were collected by la-
vage with 1 ml HBSS three times. These were then resuspended in either heat-induced antigen retrieval (high pH TRS, DAKO) for anti-
CD3 or protease K treatment (20 g/ml at room temperature) forcMEM and plated in a cell culture-treated petri dish for 45 min at
37C to remove adherent cells. Single-cell suspensions were pre- anti-CD8 staining. Endogenous biotin was blocked using the Biotin
Block (DAKO, per manufacturer’s instructions). Anti-CD3 (1:100, rab-pared from spleen and lymph nodes by disruption in a Dounce
homogenizer followed by passage through 90 m nylon mesh. bit polyclonal, DAKO) staining was performed for 60 min at room
temperature, followed by anti-rabbit secondary (DAKO, Rabbit Envi-Splenocytes and peripheral blood lymphocytes (PBL) were depleted
of erythrocytes using a buffered ammonium chloride solution (Gey’s sion) for 30 min. Anti-CD8 staining used 1:80 dilution of monoclonal
rat anti-CD8b (Caltag, clone CT-CD8b) for 60 min at room tempera-Solution). Lungs, salivary gland, and kidney were dissociated by
pressing though wire mesh, and lymphocytes were isolated using ture, followed by 1:200 dilution of biotinylated rabbit anti-rat (Vector,
BA-4000) for 30 min at room temperature. DAB (Zymed) was usedhistopaque 1083 (Sigma Diagnostics, Inc., 1083-1). After perfusion
with 5 ml PBS through the hepatic portal vein, livers were excised as the chromogen.
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